Fast Track Novel Vaccines for a fast Growing Global Aquaculture Industry

The increasing number of infections by all kind of pathogens is a major problem for the fish industry all over the world. To run aquaculture in a safe, efficient and sustainable way, state of the art vaccines are urgently needed to enable the production of high-quality edible fish for a healthy and cost-effective diet for the globally growing population. W42 is partner of an international consortium comprising different European companies covering all areas of modern fish-industry and health management. Our experts are focused on the development and use of ‘traditional’ high-efficient vaccines that are produced individually for our customers, based on their specific needs. Furthermore development of different recombinant vaccines using the powerful expression platform Pichia pastoris are actually running with great success. First trials by immunization and challenge experiments demonstrate the power of our technology. Basically we offer the development and production of customer specific vaccines (GMO and non-GMO) based on the analysis of samples directly from the individual fish-farm. By this unique service we can support our customers individually to run modern aquaculture with maximal outcome.

Recombinant vaccines under development:

Viral glycoprotein Typ1: production established

Viral glycoprotein Typ2: production process under development

VLP-Typ1:  production - established

                 purification - established

                  immune response in fish - verified

                  challenge trial - RPS significant better than product on market

                  GMP production - scheduled for 2020

                  field trial - scheduled for 2020

VLP-Typ2:  production established

                  purification established

                  immune response in fish - verified


Our partners for management of our global aquaculture activities:





Our scientific partners organized/financed by the EU:





 VLP TypI in TEM